Analyst Suggest Buying Questcor, JP Morgan Ups Stake in Lam Research
Questcor Pharmaceuticals, Inc.(NASDAQ:QCOR): Leerink says StreetSweeper’s second investigative report on Questcor did not contain any new information that changed its positive opinion on the stock. The firm said it would be aggressive buyers of Questcor shares now that the risk of a negative surprise from StreetSweeper has been removed.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
To contact the reporter on this story: Derek Hoffman at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org